‘Imitrex, resulted in 68% of participants experiencing relief. If this drug can receive such attention and praise with a record of 68% patient relief, shouldn’t a therapy that has no side effects and has an 81% success rate among migraine sufferers receive at least as much attention and at least be offered as another option to those individuals who suffer from migraine headaches? ‘
